Aristea Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Aristea Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) (NCT05448391) | Aristea Therapeutics, Inc. | 2022-09-13 |
| A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS) (NCT05348681) | Aristea Therapeutics, Inc. | 2022-07-18 |
| A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) (NCT05194839) | Aristea Therapeutics, Inc. | 2022-01-05 |
| A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects (NCT05023811) | Aristea Therapeutics, Inc. | 2021-08-11 |
| A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model (NCT04105959) | Aristea Therapeutics, Inc. | 2019-07-25 |
| A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) (NCT03988335) | Aristea Therapeutics, Inc. | 2019-02-13 |
Track Aristea Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.